<!DOCTYPE html>
<html lang="pt">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">    
    <title>
        Projeto 
    </title>
    <script type="text/javascript" src="inicio.js"></script>
    <link rel="stylesheet" href="index1.css">
    <link rel="stylesheet" href="mudarcss.css">
    <link rel="icon" type="image/x-icon" href="logo.png">
</head>
<body id="topo">
    <div id="mudarcss">
        <input type="checkbox" id="theme-switcher">
        <div id="app-container">
            <div class="theme-switcher-area">
                <label for="theme-switcher" class="theme-switcher-button">
                    </label>
            </div>
            <div class="header">
                <aside>
                    <ul id="menuOculto" class="menuOculto">
                        <a href="javascript: void(0)" class="btnFechar" onclick="fecharNav()">&times;</a>
                        <a href="inicio.html">Home</a>
                        <a href="inicio.html#conth1">Contactos</a>
                        <a href="inicio.html#teamh1">Team</a>
                        <a href="relatorio.html" target=”_blank”>Relatório</a>
                    </ul>
                </aside>
              <nav class="navbar navbar-default navbar-fixed-top">
                <div class="container">
                    <div class="principal1">
                        <span onclick="abrirNav()"><img id="imagem" src="logo.png" alt="logotipo"></span>
                    </div>
                </div>
              </nav>  
            </div>
                <section class="secção1">
                    <div class="informacao" class="card">
                        <div class="card">
                            <h2 id="def.">Nanotechnologies</h2>
                            <p> 
                                Nanotechnologies applied to the treatment of lung cancer represent transformative and promising areas of modern medicine, 
                                as previously mentioned. This field, which has evolved significantly over the last few decades, reflects advances in vast 
                                disciplines, including chemistry, biology, and physics, with a direct impact on oncology. The development of technologies 
                                capable of manipulating materials on a nanometric scale has brought new solutions to complex challenges in the treatment 
                                of lung tumours, one of the most lethal and aggressive forms of cancer.
                                For a better understanding of this report, we will look at the history of nanotechnology.
                                The idea of nanotechnology was first proposed in 1959 by Richard Feynman, a physicist, during a lecture entitled ‘There's 
                                a lot of space down there’. He predicted that in the future it would be possible to control atoms and molecules to create 
                                structures and technologies.<br>
                                This visionary concept only began to be realised in the 1980s and 1990s, with the development of tools such as the scanning 
                                probe microscope, which allowed scientists to manipulate matter at extremely small levels.
                                Then, in the 1990s, nanotechnology was applied to medicine, especially in the development of drug delivery systems.
                                Then there were the first attempts to use nanotechnology in cancer treatments, with nanoparticles made from liposomes and 
                                biodegradable polymers, which were only approved in 1995.<br>
                                In the 2000s and 2010s, nanoparticles were applied for the first time in pre-clinical studies for the selective delivery 
                                of chemotherapy drugs. With this sophisticated advance in nanoparticles, they began to be used, enabling the controlled 
                                release of drugs and the combined use of chemotherapy and radiotherapy.<br>
                                With regard to the future, it can be said that in recent years nanotechnologies have been applied in immunotherapy, helping 
                                to direct the immune system against cancer cells. In addition, liquid biopsy techniques make it possible to detect tumour 
                                markers in the blood, which consequently makes it possible to make earlier and, above all, less invasive diagnoses.<br>
                                The future of these small-scale technologies therefore promises increasingly significant advances, with the development of 
                                programmable nanoparticles and nano robots that will be able to deliver drugs ultra precisely, ultimately personalising treatment based on the genetic profile of the tumour. These innovations bring longer life expectancy, fewer side effects and better results for all patients.
                                <center>
                                    <img src='hist.png' style='width:90%'> 
                                </center>
                            </p>
                            <hr>
                            <h2 id="Historia">Biomedical Aplications </h2>
                            <p>
                                The biomedical applications of nanotechnologies in the treatment of lung cancer have shown enormous potential to transform the 
                                clinical approach to this disease, one of the most lethal globally. The development of specific nanomaterials for the treatment 
                                of lung cancer aims to overcome the limitations of traditional therapies, such as chemotherapy and radiotherapy, which often lack 
                                selectivity and can cause significant side effects. <br>
                                Of the many biomedical applications that exist for this type of cancer, the one that stands out the most is targeted drug delivery.
                                This is achieved through the engineering of nanoparticles, such as liposomes, gold nanoparticles and polymeric nanoparticles. 
                                These are designed to carry chemotherapeutic agents in a controlled manner and release them directly into tumour cells. 
                                The nanoparticles can be functionalised with ligands that recognise the receptors expressed on the lung cancer cells in the case, 
                                minimising the exposure of healthy tissues to the drug. This increases therapeutic efficacy while reducing adverse reactions, which 
                                improves systemic chemotherapy somewhat. <br>
                                However, as mentioned above, this is only the biomedical application that stands out most in this type of cancer, as there are many
                                others such as being used for diagnostics and theranostics, for advanced therapies such as photothermal therapy, for RNA-based 
                                therapies, and for overcoming biological barriers. 
                                <center>
                                    <img src='bio.png' style='width:90%'> 
                                </center>
                            </p>
                            <h2 id="vantagens&desvantagens">Properties </h2>
                            <p>
                                <center>
                                    <img src='prop.png' style='width:90%'> 
                                </center>                
                            </p>
                            <hr>
                            <h2 id="futuro">Production </h2>
                            <p>
                                The production of gold nanoparticles (AuNPs) for the treatment of lung cancer involves a 
                                series of complex processes, with the aim of creating particles that are safe, effective 
                                and suitable for therapeutic and diagnostic applications. AuNPs are valued in nanomedicine 
                                due to their biocompatibility, stability and ability to functionalise with a variety of 
                                molecules, which allows for great versatility in cancer therapy. In order to be effective 
                                in the treatment of lung cancer, AuNPs must be carefully synthesised and prepared to 
                                ensure that they have the necessary characteristics to target tumour tissue precisely 
                                and safely. <br>
                                The first step in the production of AuNPs is the choice of synthesis method, which can 
                                be physical, chemical or biological. Chemical methods are the most common and use reducing 
                                agents to transform gold salts (such as gold chloride) into gold nanoparticles. In this 
                                process, the addition of stabilising agents is essential to control the size and shape of 
                                the nanoparticles and prevent them from aggregating. Chemical synthesis methods have the 
                                advantage of being fast and controllable, allowing the production of AuNPs with specific 
                                sizes and shapes, such as spheres, rods or stars, each with unique properties. Physical 
                                methods, such as evaporation and condensation, are less common due to high costs and the 
                                need for specialised equipment, but can be used to produce AuNPs of high purity. <br>
                                A promising approach is biological synthesis, which uses living organisms such as bacteria, 
                                fungi and plants to reduce gold salts and produce AuNPs. This method is considered more 
                                sustainable and less toxic, as it avoids the use of potentially dangerous chemical agents. 
                                In addition, AuNPs produced by biological methods tend to be biocompatible, a desirable 
                                characteristic for applications in medicine. However, control over the size and shape of 
                                the nanoparticles in this method is more difficult to achieve, which may limit their use 
                                in some specific applications. <br>
                                After synthesis, the AuNPs are functionalised to confer specific properties that improve 
                                their efficiency in the treatment of lung cancer. Functionalisation consists of adding 
                                bioactive molecules, such as drugs, antibodies or peptides, to the surface of the 
                                nanoparticles. This step is crucial as it allows the AuNPs to recognise and bind specifically 
                                to cancer cells, maximising the effectiveness of the treatment and minimising damage to 
                                healthy tissues. Functionalisation with polyethylene glycol (PEG), for example, is often
                                used to increase the biocompatibility of AuNPs and prolong their circulation in the body, 
                                avoiding early recognition by the immune system.<br>
                                In addition, the production of AuNPs for cancer treatment requires rigorous testing to 
                                guarantee the stability and safety of the nanoparticles. The characterisation of AuNPs, 
                                including analysis of their size, shape, surface charge and stability, is essential to 
                                confirm that they have the desired properties. Techniques such as electron microscopy, 
                                UV-vis spectroscopy and dynamic light scattering are often used to carry out these analyses. 
                                In vitro and in vivo tests are also needed to assess the effectiveness of AuNPs in eliminating 
                                cancer cells, their ability to penetrate tumour tissue and their toxicity to healthy cells.<br>
                                In short, the production of gold nanoparticles for the treatment of lung cancer is a process 
                                that requires precision and control over multiple stages, from synthesis to functionalisation 
                                and final characterisation. The ability to adjust the size, shape and surface of AuNPs makes 
                                it possible to adapt these particles to different therapeutic strategies, such as photothermal 
                                therapy and controlled drug release. With advances in production techniques and growing 
                                knowledge about the toxicity and biocompatibility of AuNPs, this approach represents a 
                                promising alternative for the treatment of lung cancer, with the potential to offer more 
                                effective, selective and less invasive treatments.  
                                <center>
                                    <img src='prod.png' style='width:90%'> 
                                </center>
                            </p>
                            <hr>
                            <h2 id="futuro">Action Mechanisms </h2>
                            <p>
                                As nanopartículas de ouro (AuNPs) apresentam diversos mecanismos de atuação que as tornam ferramentas promissoras no tratamento do cancro do pulmão, oferecendo elevada especificidade e eficácia ao interagir com as células tumorais. Entre os principais mecanismos estão a terapia fototérmica, a terapia fotodinâmica, a libertação controlada de fármacos, a imunoterapia e a terapia genética, bem como a possibilidade de aplicações teranósticas, que combinam diagnóstico e tratamento.
                                <br>A terapia fototérmica (PTT) aproveita a capacidade das AuNPs de absorverem luz no comprimento de onda próximo do infravermelho (NIR) e de a converterem em calor. Este aquecimento localizado, resultante da exposição a lasers NIR, destrói as células tumorais ao danificar proteínas e ácidos nucleicos, levando à morte celular por necrose ou apoptose. Este método é especialmente vantajoso pela sua seletividade, uma vez que atinge preferencialmente as células tumorais e preserva os tecidos saudáveis circundantes, sendo uma abordagem eficaz para o tratamento de tumores sólidos no pulmão.
                                <br>Já a terapia fotodinâmica (PDT) implica a funcionalização das AuNPs com moléculas fotossensibilizadoras que, ao serem ativadas pela luz, produzem espécies reativas de oxigénio (EROs) capazes de oxidar estruturas celulares essenciais, promovendo a morte das células tumorais. Este método é útil para tumores que apresentam resistência aos tratamentos convencionais, uma vez que as EROs atuam de forma independente das vias de sinalização que podem estar alteradas no cancro.
                                <br>Outro mecanismo relevante é a libertação controlada de fármacos. As AuNPs, funcionalizadas com quimioterápicos, atuam como vetores para o transporte direcionado e gradual dos medicamentos até ao tumor. Esta entrega seletiva permite a libertação controlada dos fármacos em resposta ao pH ácido do microambiente tumoral, concentrando a ação terapêutica nas células cancerígenas e reduzindo os efeitos colaterais. Desta forma, as AuNPs permitem manter uma concentração eficaz do fármaco no tumor ao longo do tempo, aumentando a eficácia do tratamento.
                                <br>As AuNPs têm também aplicações promissoras em imunoterapia, ao serem funcionalizadas com moléculas imunomoduladoras que estimulam o sistema imunológico a atacar as células cancerígenas. As nanopartículas podem transportar antigénios tumorais que "ensinam" o sistema imunológico a identificar e a destruir as células malignas. No caso do cancro do pulmão, esta abordagem visa combater a imunossupressão característica do ambiente tumoral, ativando uma resposta imune antitumoral eficaz.
                                <br>Outro avanço significativo é o uso das AuNPs em terapias genéticas, como o transporte de RNA de interferência (siRNA) ou DNA, visando silenciar genes oncogénicos ou ativar genes supressores de tumor específicos. Este mecanismo permite uma abordagem personalizada, com a modificação precisa da expressão génica em células cancerígenas, promovendo a morte celular ou inibindo a progressão do tumor de forma direcionada.
                                <br>Para além disso, as AuNPs oferecem a possibilidade de aplicação teranóstica, integrando diagnóstico e terapia num único sistema. Funcionalizadas com moléculas fluorescentes ou radioativas, as AuNPs podem ser utilizadas para monitorização em tempo real do tumor, facilitando o acompanhamento da resposta ao tratamento e proporcionando um planeamento terapêutico mais preciso. Por se acumularem preferencialmente no tumor, as AuNPs fornecem informações sobre a localização e o tamanho do tumor, permitindo ajustar o tratamento conforme necessário.
                                <br>Em resumo, os mecanismos de atuação das AuNPs para o tratamento do cancro do pulmão abrangem métodos terapêuticos e de diagnóstico altamente seletivos, com o potencial de melhorar a eficácia do tratamento e reduzir os efeitos adversos. Estas abordagens representam um avanço importante para o desenvolvimento de terapias mais seguras e personalizadas, com perspetivas promissoras para o combate ao cancro do pulmão.
                                <center>
                                    <img src='at.png' style='width:90%'> 
                                </center>
                            </p>
                        </div>
                    </div> 
            <div class="nave">
                <aside class="card">
                    <ul class="unica">
                        <li>
                            <a href="/documents/index1.html"><h1>Telemedicina</h1></a>
                        </li>
                        <hr>
                        <br>
                        <li><a href="/documents/index2.html"><h1>Áreas</h1></a></li>
                        <hr>
                        <ul class="unica1">
                            <li><a href="/documents/Areas/telecirurgia.html"><span id="indice">Telecirugia</span></a></li>
                            <ul style="padding-left: 20px; font-size: medium;">        
                                <li><a href="#def.">[1].<span id="indice">Definição</span></a></li>
                                <li><a href="#Historia">[2].<span id="indice">História</span></a></li>
                                <li><a href="#benefício">[3].<span id="indice">Vantagens e Desvantagens</span></a></li>
                                <li><a href="#desafios">[4].<span id="indice">Futuro</span></a></li>
                            </ul>
                            <li><a href="/documents/Areas/teleconsulta.html"><span id="indice">Teleconsulta</span></a></li>
                            <li><a href="/documents/Areas/teletriagem.html"><span id="indice">Teletriagem</span></a></li>
                            <li><a href="/documents/Areas/telemonitorizacao.html"><span id="indice">Telemonitorização</span></a></li>
                        </ul>
                    </ul>
                </aside>        
            </div>
        </section>
           
        <a href="#" id="link-topo" data-anima="scroll"><img src="icons8-estetoscópio-64.png" alt="voltar ao topo" width="50px"></a>
        <div class="Footer">
            <hr>
            <div id="logos">
                <img id="logoprojeto" src="logo.png" alt="">
                <a href="https://www.estsetubal.ips.pt/" target="_blank"><img id="logoest" src="logo-ESTS.png" alt=""></a>
            </div>
        </div>
        <div>
            <p id="fim"><a href="/about.html">About</a> © LTB - Tecnologia de Setúbal • Nanotecnologia • 2024/2025</p>
        </div>
    
    </div>
</body>
</html>
    
